期刊文献+

抗人类癌抗原单克隆抗体的制备与肝组织中的鉴定

Preparation and identification of anti-HCA monoclonal antibody
下载PDF
导出
摘要 目的运用杂交瘤技术制备人类癌抗原(Human carcinoma antigen,HCA)的IgG单克隆抗体。方法用现有的HCA-IgM抗体HAE3分别从PC3、PCaT及LCaT总蛋白中分离纯化得到三组糖蛋白复合物组分作为抗原分别免疫Balb/c小鼠,获得鼠抗人HCA抗体.并对这些抗体进行ELISA检测效价、western-blot以及免疫组化等分析,筛选合适的抗体进行下一部分研究。结果共制备出62株高亲和力、高特异性并且针对不同抗原结合位点的鼠抗人HCA单克隆抗体。通过在肝组织上的鉴定,发现这些抗体无论效价、western-blot以及免疫组化都适合进行进一步研究。结论我们利用天然HCA抗原制备了高亲和力,高特异性并且针对不同抗原结合位点的单克隆抗体,为我们进一步研究其结构及功能提供了有力的特异的工具。 Objective To prepare murine mAbs against human HCA by hybridoma technique. Methods We isolated HCA from prostatic carcinoma cells ( PC3 ), prostatic carcinoma tissues (PCaT) and lung cancer tissues (LCaT) with immunoaffinity chro- matography. In order to obtain antibodies with high affinity and specificity against HCA, we used all of these three parts of HCA to im- munize Balb/c mice and generated hybridoma cell strains secreting murine mAbs against human HCA by hybridoma technique. The an- tibodies against HCA were selected by Western blot, ELISA and immunohistochemistry. Result 62 hybridoma cell lines stably secre- ting specific mAbs against human HCA were established. The murine mAb against HCA would be efficient affinity reagent for the fur- ther functional studies of HCA on liver tissues. Discussion The murine mAb against HCA would be efficient affinity reagent for the further functional studies of HCA.
出处 《肝胆外科杂志》 2014年第4期308-310,共3页 Journal of Hepatobiliary Surgery
关键词 人类癌抗原 杂交瘤 单克隆抗体 肿瘤标志物 Human carcinoma antigen Hybridoma technique Monoclonal antibody Tumor marker
  • 相关文献

参考文献9

  • 1Daiss JL,Camey JL,Cartun R,et al.Human Carcinoma Antigen:A Marker Useful for Discriminating between Benign Prostatic Hyperplasia and Prostate Cancer.Journal of Clinical Ligand Assay.2003; 26:177-180.
  • 2emperman H,Wijnands Y,Wesseling J,et.al.The mucin epiglycanin on TA3/Ha carcinoma cells prevents a(6) β(4)-mediated adhesion to laminin and kalinin and E-cadherin-mediated cell-cell interaction.J Cell Biol.1994; 127:2071-2080.
  • 3Codington JF,Bhavanandan VP,Block K,et al.Antibody to epiglycanin and radioimmunoassay to detect epiglycanin-related glycoproteins in body fluids of cancer patients.J Natl Cancer Inst.1984; 73:1029-1038.
  • 4Codington JF,Haavik S,Hui Z,et al.Immunoassays for determining the concentration of a carcinoma-specific antigen in the blood of cancer.Glycoconjugate J.1993; 10:319.
  • 5Daiss JL,Carney JL,Cartun R,et al.Human Carcinoma Antigen:A Marker Useful for Discriminating between Benign Prostatic Hyperplasia and Prostate Cancer.Journal of Clinical Ligand Assay.2003 ; 26:177-180.
  • 6Rongshan L,Jorge LY,Patricia AB,et al.Frequent Expression of Human Carcinoma-Associated Antigen,a Mucin-Type Glycoprotein,in Cells of Prostatic Carcinoma.Arch Pathol Lab Med.2004;128:1412-1417.
  • 7Torunn Thingstad,Svein Haavik,Katrine Hansen,et al.Human carcinoma-associated antigen(HCA),isolated from the endometrial carcinoma cell line KLE-1 and ascitic fluid of a patient with ovarian carcinoma; comparison with epiglycanin.European Journal of Pharmaceutical Sciences.1998; 6:121-129.
  • 8F.B.Fromowitz,M.V.Voila,S.Chao,et al.Ras P21 expression in the progression of breast cancer.HumPathol.1987(18):1268-1275.
  • 9Thingstad T,Haavik S,Hansen K,Sletten K,Codington JF,Barsett H.Human carcinoma-associated antigen(HCA),isolated from the endometrial carcinoma cell line KLE-1 and ascitic fluid of a patient with ovarian carcinoma; comparison with epiglycanin.European Journal of Pharmaceutical Sciences.1998 ; 6:121-129.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部